Glaucoma News

Timolol maleate 0.5% microdrops delivered with the Nanodropper Adaptor met three noninferiority endpoints in lowering IOP compared with conventional timolol drops, according to a study.

With the continued increase in the older patient population and a nearly 20% decline in the health care workforce, there is an urgent need to expand ocular telehealth, according to a speaker at the American Glaucoma Society meeting.

Before implementing a telehealth program, it is important to know what problem needs to be solved and to have a concrete goal to achieve.

In the dynamic landscape of diabetic macular edema management, the PALADIN study continues to offer helpful insights into the outcomes of IOP-lowering surgery after treatment with Iluvien.

Measuring a specific area of visual field over time with OCT guidance improved detection of visual field worsening, particularly in less severe cases of glaucoma, according to a speaker.

FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Kevin L. Waltz, OD, MD, speaks about the ViaLase femtosecond laser technology for high-precision trabeculotomy.

Smartphones are nearly ubiquitous and powerful tools that allow physicians to take better care of patients and help patients improve care for themselves, according to a speaker at the American Glaucoma Society meeting.

Patients with genetic risk for different glaucoma subtypes had an associated risk for different visual field defects, according to a study.

Patients with advanced glaucoma should be offered trabeculectomy as their primary intervention, according to a study presented at the American Glaucoma Society meeting.

The widespread adoption of microinvasive glaucoma surgery has been one of the most exciting developments in ophthalmology in the past 10 years.